Cargando…
Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us
Autores principales: | Kabelitz, Dieter, Serrano, Ruben, Kouakanou, Léonce, Peters, Christian, Kalyan, Shirin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608082/ https://www.ncbi.nlm.nih.gov/pubmed/32873864 http://dx.doi.org/10.1038/s41423-020-00537-z |
Ejemplares similares
-
Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020) -
Reply to: Vitamin C as a promoter of γδ T cells
por: Kouakanou, Léonce, et al.
Publicado: (2021) -
Vitamin C promotes the proliferation and effector functions of human γδ T cells
por: Kouakanou, Léonce, et al.
Publicado: (2019) -
Vitamin C supports conversion of human γδ T cells into FOXP3-expressing regulatory cells by epigenetic regulation
por: Kouakanou, Léonce, et al.
Publicado: (2020) -
Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
por: Bhat, Jaydeep, et al.
Publicado: (2018)